246 related articles for article (PubMed ID: 9111592)
1. Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).
Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Konopka L
Eur J Haematol; 1997 Feb; 58(2):109-13. PubMed ID: 9111592
[TBL] [Abstract][Full Text] [Related]
2. 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis.
Zaucha JM; Hałaburda K; Ciepłuch H; Hellmann A
Acta Haematol Pol; 1994; 25(2):119-27. PubMed ID: 7915075
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).
Chasty RC; Myint H; Oscier DG; Orchard JA; Bussutil DP; Hamon MD; Prentice AG; Copplestone JA
Leuk Lymphoma; 1998 Apr; 29(3-4):391-8. PubMed ID: 9684936
[TBL] [Abstract][Full Text] [Related]
4. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
[TBL] [Abstract][Full Text] [Related]
5. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
Krykowski E; Warzocha K; Robak T
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
[TBL] [Abstract][Full Text] [Related]
6. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Majumdar G; Brown S; Slater NG; Singh AK
Leuk Lymphoma; 1993 Jan; 9(1-2):149-51. PubMed ID: 8477195
[TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Blonski JZ; Robak T; Chojnowski K; Gora-Tybor J; Warzocha K; Ceglarek B; Seferynska I; Calbecka M; Kostyra A; Stella-Holowiecka B; Kloczko J; Dmoszynska A; Kowal M; Lewandowski K; Dwilewicz-Trojaczek J; Wiater E; Kuliczkowski K; Potoczek S; Hellmann A; Mital A; Skotnicki A; Nowak W; Sulek K; Zawilska K; Trelinski J
Eur J Haematol; 2013 Jul; 91(1):1-9. PubMed ID: 23521128
[TBL] [Abstract][Full Text] [Related]
9. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
10. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
[TBL] [Abstract][Full Text] [Related]
12. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
Robak T; Blonski JZ; Gora-Tybor J; Kasznicki M; Konopka L; Ceglarek B; Komarnicki M; Lewandowski K; Hellmann A; Lewandowski K; Moskwa A; Dmoszyńska A; Sokołowska B; Dwilewicz-Trojaczek A; Tomaszewska A; Sułek K; Całbecka M
Eur J Cancer; 2004 Feb; 40(3):383-9. PubMed ID: 14746857
[TBL] [Abstract][Full Text] [Related]
13. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile and serological correlation with haemolysis in DAT-positive autoimmune haemolytic anaemia patients in Bangladesh.
Mahmood A; Khatun A; Hasan M; Miah SS; Tapan MMH; Rahman A
Pathology; 2024 Jun; 56(4):565-570. PubMed ID: 38480050
[TBL] [Abstract][Full Text] [Related]
15. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
[TBL] [Abstract][Full Text] [Related]
16. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
Aslan DL; Peterson BA; Long-Tsai M; Eastlund T
Transfusion; 2006 Jan; 46(1):90-4. PubMed ID: 16398735
[TBL] [Abstract][Full Text] [Related]
17. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
19. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
20. 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.
Saven A; Lemon RH; Kosty M; Beutler E; Piro LD
J Clin Oncol; 1995 Mar; 13(3):570-4. PubMed ID: 7884417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
